Montelukast, a Leukotriene Receptor Antagonist, in Combination With Loratadine, a Histamine Receptor Antagonist, in the Treatment of Chronic Asthma
Open Access
- 11 September 2000
- journal article
- clinical trial
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 160 (16) , 2481-2488
- https://doi.org/10.1001/archinte.160.16.2481
Abstract
ASTHMA IS a significant public health concern, with a 5% to 7% prevalence in adults worldwide.1 In the United States alone, asthma affects an estimated 14 to 15 million persons.2This publication has 28 references indexed in Scilit:
- Montelukast, a Once-Daily Leukotriene Receptor Antagonist, in the Treatment of Chronic AsthmaA Multicenter, Randomized, Double-blind TrialArchives of internal medicine (1960), 1998
- Montelukast for Chronic Asthma in 6- to 14-Year-Old ChildrenJAMA, 1998
- Comparison of Regularly Scheduled with As-Needed Use of Albuterol in Mild AsthmaNew England Journal of Medicine, 1996
- Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. ACCOLATE Asthma Trialists Group.American Journal of Respiratory and Critical Care Medicine, 1994
- Antihistamines in the treatment of asthmaClinical Reviews in Allergy, 1994
- Does the clinical experience with non‐sedating H1‐antagonists justify a reassessment of antihistamines in allergy treatment?Clinical and Experimental Allergy, 1990
- The relationship between plasma histamine concentrations and bronchial obstruction to antigen challenge in allergic rhinitisJournal of Allergy and Clinical Immunology, 1989
- Airway Responsiveness to Leukotrienes C4 and D4 and to Methacholine in Patients with Asthma and Normal ControlsNew England Journal of Medicine, 1986
- THE EFFECT OF INHALED LEUKOTRIENE-D4 IN HUMANSPublished by Elsevier ,1985
- Leukotrienes are potent constrictors of human bronchiNature, 1980